CTT-CORREIOS DE PORTUGAL/ PTCTT0AM0001 /
18/06/2024 10:44:48 | Diferencia +0.01 | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
4.20EUR | +0.24% | 810 Volumen de negocios: 3,396.20 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 629.25 millonesEUR | 2.03% | 38.14 |
GlobeNewswire
11:00
Hydrogen Powered Internal Combustion Engines are the Focus of a Live Webinar & White Paper
GlobeNewswire
11:00
Altus Formulation and Spektar Join Forces in New Specialty Company Spektus Pharma
GlobeNewswire
11:00
Future Health Index 2024 global report: Healthcare leaders turn to AI to address critical gaps in pa...
GlobeNewswire
10:30
Flash News: OKX Lists ZKsync's ZK Token on its Perpetual Futures Market, Expanding Trading Options
GlobeNewswire
10:01
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD ...
GlobeNewswire
10:00
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors w...
GlobeNewswire
10:00
FSLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fastly, Inc. Investors with Su...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
Nokia and Google Cloud collaborate to help developers worldwide create 5G applications faster with t...
GlobeNewswire
9:55
Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
GlobeNewswire
9:32
Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Smal...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página